C1q acts in the tumour microenvironment as a cancer-promoting factor independently of complement activation.
Bulla R, Tripodo C, Rami D, Ling GS, Agostinis C, Guarnotta C, Zorzet S, Durigutto P, Botto M, Tedesco F.
Nat Commun. 2016 Feb 1;7:10346. doi: 10.1038/ncomms10346.

2016

Heterotypic paracrine signaling drives fibroblast senescence and tumor progression of large cell carcinoma of the lung.
Lugo R, Gabasa M, Andriani F, Puig M, Facchinetti F, Ramírez J, Gómez-Caro A, Pastorino U, Fuster G, Almendros I, Gascón P, Davalos A, Reguart N, Roz L, Alcaraz J.
Oncotarget. 2016 Dec 13;7(50):82324-82337. doi: 10.18632/oncotarget.10327.

2016

Parametric and nonparametric two-sample tests for feature screening in class comparison: a simulation study
Landoni E, Ambrogi F, Mariani L, Miceli R.
Epidemiology Biostatistics and Public Health - 2016, Volume 13, Number 2. e11808-1-11. doi: 10.2427/11808

2016

Stromal Activation by Tumor Cells: An in Vitro Study in Breast Cancer.
Merlino G, Miodini P, Paolini B, Carcangiu ML, Gennaro M, Dugo M, Daidone MG, Cappelletti V.
Microarrays (Basel). 2016 May 18;5(2). pii: E10. doi: 10.3390/microarrays5020010.

2016

MicroRNA Profile of Lung Tumor Tissues Is Associated with a High Risk Plasma miRNA Signature.
Fortunato O, Verri C, Pastorino U, Sozzi G, Boeri M.
Microarrays (Basel). 2016 Jul 5;5(3). pii: E18. doi: 10.3390/microarrays5030018.

2016

Mesenchymal Transition of High-Grade Breast Carcinomas Depends on Extracellular Matrix Control of Myeloid Suppressor Cell Activity.
Sangaletti S, Tripodo C, Santangelo A, Castioni N, Portararo P, Gulino A, Botti L, Parenza M, Cappetti B, Orlandi R, Tagliabue E, Chiodoni C, Colombo MP.
Cell Rep. 2016 Sep 27;17(1):233-48. doi: 10.1016/j.celrep.2016.08.075.

2016

Comment on 'Circulating cell-free miRNAs as biomarker for triple-negative breast cancer'-Methodological challenges in combining miRNAs as circulating biomarkers.
Verderio P, Bottelli S, Lecchi M, Plebani M, Gariboldi M, Pizzamiglio S, Ciniselli CM.
Br J Cancer.
2016 May 10;114(10):e5.
doi: 10.1038/bjc.2016.1.
Epub 2016 Apr 21.

2016

Developing miRNAs signatures: a multivariate prospective
Verderio P, Bottelli S, Pizzamiglio S, and Ciniselli C
Br J Cancer. 2016 Jun 28;115(1):1-4. doi: 10.1038/bjc.2016.164.

2016

MicroRNAs and the Response of Prostate Cancer to Anti-Cancer Drugs.
Pennati M, Folini M, Gandellini P, Zaffaroni N.
Curr Drug Targets. 2016;17(3):257-65. Review.

2016

A subset of genetic susceptibility variants for colorectal cancer also has prognostic value
Noci S, Dugo M, Bertola F, Melotti F, Vannelli A, Dragani TA and  Galvan A
Pharmacogenomics J.
2016 Apr;16(2):173-9.
doi: 10.1038/tpj.2015.35.
Epub 2015 May 12.

2016

Stopping Smoking Reduces Mortality in Low-Dose Computed Tomography Screening Participants
Pastorino U, Boffi R, Marchianò A, Sestini S, Munarini E, Calareso G, Boeri M, Pelosi G, Sozzi G, Silva M, Sverzellati N, Galeone C, La Vecchia C, Ghirardi A, Corrao G
J Thorac Oncol. 2016 May;11(5):693-9. doi: 10.1016/j.jtho.2016.02.011.
Epub 2016 Feb 24.

2016

Low-dose computed tomography for lung cancer screening: comparison of performance between annual and biennial screen.
Sverzellati N, Silva M, Calareso G, Galeone C, Marchianò A, Sestini S, Sozzi G, Pastorino U.
Eur Radiol. 2016 Nov;26(11):3821-3829.
Epub 2016 Feb 11. doi: 10.1007/s00330-016-4228-3

2016

microRNA Expression in Sentinel Nodes from Progressing Melanoma Patients Identifies Networks Associated with Dysfunctional Immune Response.
Vallacchi V, Camisaschi C, Dugo M, Vergani E, Deho P, Gualeni A, Huber V, Gloghini A, Maurichi A, Santinami M, Sensi M, Castelli C, Rivoltini L, Rodolfo M.
Genes (Basel). 2016 Dec 14;7(12). pii: E124.

2016

Dissecting the role of microRNAs in prostate cancer metastasis: implications for the design of novel therapeutic approaches. 
Doldi V, Pennati M, Forte B, Gandellini P, Zaffaroni N
Cell Mol Life Sci. 2016 Jul;73(13):2531-42. doi: 10.1007/s00018-016-2176-3. Epub 2016 Mar 12.

2016

Integration of genome scale data for identifying new players in colorectal cancer. 
Sokolova V, Crippa E,
Gariboldi M. 

World J Gastroenterol.
2016 Jan 14;22(2):534-45.
doi: 10.3748/wjg.v22.i2.534.

2016

Screening with Low-Dose Computed Tomography Does Not Improve Survival of Small Cell Lung Cancer.
Silva M, Galeone C, Sverzellati N, Marchianò A, Calareso G, Sestini S, La Vecchia C, Sozzi G, Pelosi G, Pastorino U.
J Thorac Oncol. 2016 Feb;11(2):187-93. doi: 10.1016/j.jtho.2015.10.014.
Epub 2015 Dec 23.

2016

Conversion to stem-cell state in response to microenvironmental cues is regulated by balance between epithelial and mesenchymal features in lung cancer cells.
Andriani F, Bertolini G, Facchinetti F, Baldoli E, Moro M, Casalini P, Caserini R, Milione M, Leone G, Pelosi G, Pastorino U, Sozzi G,
Roz L.
Mol Oncol. 2016 Feb;10(2):253-71. doi: 10.1016/j.molonc.2015.10.002.
Epub 2015 Oct 22.

2016

Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma.
Pintarelli G, Dassano A, Cotroneo CE, Galvan A, Noci S, Piazza R, Pirola A, Spinelli R, Incarbone M, Palleschi A, Rosso L, Santambrogio L, Dragani TA, Colombo F.
Oncotarget. 2016 May 10;7(19):27889-98. doi: 10.18632/oncotarget.8556.

2016

Overcoming melanoma resistance to vemurafenib by targeting CCL2-induced miR-34a, miR-100 and miR-125b.
Vergani E, Di Guardo L, Dugo M, Rigoletto S, Tragni G, Ruggeri R, Perrone F, Tamborini E, Gloghini A, Arienti F, Vergani B, Deho D, De Cecco L, Vallacchi V, Frati P, Shahaj E, Villa A, Santinami M, De Braud F, Rivoltini L, Rodolfo M.
Oncotarget. 2016 Jan 26;7(4):4428-41. doi: 10.18632/oncotarget.6599.

2016

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié

Progetto finanziato con

il contributo Airc 5x1000

Copyright © 2017 INT

Fondazione IRCCS Istituto Nazionale dei Tumori

Tutti i diritti sono riservati

website by Studio Luvié